Everolimus Plus CsA Improves Renal Function in Kidney Transplant Recipients - Medscape |
![]() |
MedscapeBoth everolimus groups were statistically noninferior to the MPA control group for the composite efficacy end point and for renal function at 12 months. ... read more |